DCLK3 and susceptibility to pneumonia measurement: To compare the efficacy of CLR and ERY on MRSP-induced pneumonia in vivo, we orally administered either CLR or ERY (150 mg/kg every 12 h) to a mouse model of intratracheal MRSP infection.